Premium
Outcome of hospital outpatient treatment of functional gastrointestinal disorders
Author(s) -
Basnayake Chamara,
Kamm Michael A.,
Salzberg Michael,
Stanley Annalise,
Khera Angela,
Burrell Kathryn,
WilsonO’Brien Amy,
Hebbard Geoffrey,
Thompson Alexander J.
Publication year - 2019
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.14067
Subject(s) - medicine , irritable bowel syndrome , functional gastrointestinal disorder , outpatient clinic , physical therapy
Background Functional gastrointestinal disorders (FGID) are the commonest conditions observed in gastrointestinal (GI) practice, yet the outcomes of their outpatient care are not known. Aim To evaluate the outcome for patients with FGID attending a specialist GI clinic. Methods Consecutive, newly referred patients with a FGID attending a specialist GI clinic in a tertiary hospital, over a 1‐year period were reviewed and then completed a phone survey to assess current symptoms. Results Of 102 patients, 57% had irritable bowel syndrome, 28% functional dyspepsia and 15% other functional disorders. At interview, a median of 402 days after the last consultation 38% expressed symptom improvement, but 64% remained concerned about their condition despite 62% having been reassured. After treatment, 50% of employed patients took time off work because of gut symptoms. Functional dyspepsia patients were less likely to be symptomatically improved than other FGID (21% vs 45%, P = 0.02). Patients given a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols were more likely than others to achieve symptom improvement (53% vs 31%, P = 0.03); PPI‐treated patients were less likely to experience improvement (22% vs 44%, P = 0.05); other treatments did not predict outcome. Number of visits, seniority of clinician, duration of care and comorbidities did not predict outcome. Conclusion One year after attending a specialist GI clinic a minority of patients with FGID were symptomatically improved. Failure to benefit by many patients may relate to the nature of patients and conditions being treated or the limited nature and range of treatments offered. Different models of care, including more diverse multidisciplinary models, should be explored.